Target intelligence / Profile preview

RNA, U6 small nuclear 1333, pseudogene (RNU6-1333P)

Target
RNU6-1333P
Molecular classification
Pseudogene, Small nuclear RNA pseudogene
01

Overview

**RNA, U6 small nuclear 1333, pseudogene (RNU6-1333P)** is a human pseudogene that corresponds to a nonfunctional, processed genomic copy related to the U6 small nuclear RNA gene[1][3][7][6]. U6 small nuclear RNA itself plays a central role as a component of the spliceosome complex that removes introns from precursor mRNAs, but *pseudogenes* such as RNU6-1333P do not produce functional RNAs or proteins[2][7]. Instead, these pseudogenes are generated through retrotransposition events, particularly by LINE-1 (L1) retrotransposon activity, and are dispersed in the genome as inactive copies[2]. There is no evidence supporting a protein product, direct biological function, or involvement in disease. RNU6-1333P is not classified as a therapeutic target, receptor, enzyme, or related druggable entity[1][3][7].\n\n**Key clarifications:**\n- RNU6-1333P is a pseudogene, not a receptor, enzyme, transporter, or direct therapeutic target.\n- There are no known drug interactions, clinical biomarkers, disease associations, or safety considerations related to this pseudogene[7][3].\n- Its significance is primarily in genome annotation and in studies of retrotransposition and genome evolution[2].

Other names
RNU6-1333PRNA, U6 Small Nuclear 1333, Pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 1333, pseudogene (RNU6-1333P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1333, pseudogene (RNU6-1333P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call